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SATURATION EFFECTS ON T-CELL ACTIVATION IN A MODEL OF A
MULTI-STAGE PATHOGEN
MICHAEL SHAPIRO AND EDGAR DELGADO-ECKERT
Abstract. In [5], we studied host response to a pathogen which uses a cycle of immunologically
distinct stages to establish and maintain infection. We showed that for generic parameter values,
the system has a unique biologically meaningful stable fixed point. That paper used a simplified
model of T-cell activation, making proliferation depend linearly on antigen-T-cell encounters.
Here we generalize the way in which T-cell proliferation depends on the sizes of the antigenic
populations. In particular, we allow this response to become saturated at high levels of antigen.
As a result, we show that this family of generalized models shares the same steady-state behavior
properties with the simpler model contemplated in [5].
1. Introduction
Pathogens that cyclically traverse different stages during their life cycle or during an infection
process have been studied since the late nineteenth century. Important examples are Plasmodium
([6]), Trypanosoma ([16]), and the family of herpes viruses, including the Epstein-Barr virus (EBV)
([15], [14]). One remarkable characteristic of infections with many of such pathogens is life-long
persistent infection ([8], [15], [10], [6], [16]).
In [5], we introduced a model of a pathogen that uses a cycle of n antigenically distinct stages
to establish and maintain infection. The model is given by 2n differential equations,
dSj
dt
= Fj(S, T ) = rj−1fj−1Sj−1 − ajSj − fjSj − pjSjTj(1)
dTj
dt
= Gj(S, T ) = cjSjTj − bTj .
Here Sj denotes the pathogen population at stage j, Tj is the cognate host response. The indices
j = 0, . . . , n− 1 are taken modulo n. The parameters represent the following processes:
• aj is the decay rate of stage Sj . If aj is negative, this state proliferates.
• fj is the rate at which stage Sj is lost to become (or produce) stage Sj+1.
• rj is an amplification factor in the process by which stage Sj becomes (or produces) stage
Sj+1. For example, the loss of one lytically infected cell may produce rj ∼= 104 free virus.
• pj represents the efficacy of the immune response Tj in killing infected stage Sj.
• cj is the antigenicity of stage Sj , i.e., its efficacy in inducing proliferation of immune response
Tj.
• b is the natural death rate of the response Tj. We assume it is the same for all stages.
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We refer to the parameters collectively as θ. Except for aj, j = 0, . . . , n− 1, these are assumed
non-negative.
Our flagship result is that while (1) has 2n fixed points for generic values of θ, exactly one of
these is biologically meaningful and stable ([5]).
Let us focus for the moment on the terms −pjSjTj of Fj and cjSjTj of Gj . The term −pjSjTj
represents the killing of pathogen at stage j (usually infected cells in a particular differentiation
state) by the cognate T-cell population. This takes place pursuant to an encounter between T-cells
and infected cells displaying antigen complexed to MHC. To a first approximation the rate of such
encounters is proportional to the product of the sizes of the two populations. Thus, to a first
approximation, this term reflects the mechanism of the biological process it represents.
The term cjSjTj of Gj represents proliferation of T-cells in response to the presence of antigen.
Here, the underlying biological processes are considerably more complicated, involving a number
of cell types. Initially, T-cells are activated and begin to proliferate only in response to antigen
presenting cells, particularly dendritic cells (DCs) ([12]). The density of presented antigen is known
to affect these T-cell-DC interactions ([7], [19]), eliciting differing CTL responses at different den-
sities, including T-cell exhaustion at high concentrations of presented antigen ([11]). Activated
CD8+ T-cells also exhibit central and effector memory phenotypes and the relationships between
these phenotypes is not well understood ([4]). Finally, the length of the cell cycle places a hard limit
on the rate at which the T-cell population can proliferate. Thus, the rate of T-cell proliferation
becomes saturated for large amounts of antigen ([9]). In this, they bear a similarity to the rates of
enzyme catalyzed chemical reactions (reviewed in [2], see [3] for experimental evidence).
To accommodate dose-dependent effects, we will study the system
dSj
dt
= F̂j(S, T ) = rj−1fj−1Sj−1 − ajSj − fjSj − pjSjTj(2)
dTj
dt
= Ĝj(S, T ) = ϕj(Sj)Tj − bTj .
which generalizes (1). The function Ĥ is unchanged fromH . The terms of Ĝj represent proliferation
of CTLs in response to the presence of antigen and the loss of CTLs due to death or decommis-
sioning. We use functions ϕj : [0,∞) → [0,∞) to denote the dose-response curves. We assume
that for each j, ϕj(0) = 0, and that for x ∈ (0,∞), ϕ′j(x) exists and is positive. In particular,
each ϕj is continuous on [0,∞) and strictly monotone increasing. The possibility of dose-response
saturation arises from the case where there is an mj ∈ R so that limx→∞ ϕj(x) = mj . We show
that with appropriate modification, the major results of [5] hold for (2). While the term ϕj(Sj) is
still phenomenological in that it omits discussion of biological mechanism, we argue in Section 4
that it may well offer a way to address this limitation.
The system (2) can exhibit a behavior which does not arise with (1). In either case if aj+fj < 0,
we say that j is self-establishing. It is not hard to see that a self-establishing stage which is not
regulated will expand without bound. On the other hand, as we will show, if mj ≤ b, the host
cannot mount a response to Sj . It is immuno-incompetent with respect to this stage. If j is
self-establishing and the host is immuno-incompetent with respect to j, we say that the parameter
set is fatal. If the host is immunologically incompetent at all stages we say the host is totally
immunologically incompetent. Clearly, in this case, if the basic reproductive number of the pathogen
is greater than one, infection is also fatal to the host. Accordingly, we will assume that the host is
immuno-competent for at least one stage.
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2. Background and definitions
We start by transforming (2) through a change of coordinates. For this purpose we take mj :=
limx→∞ ϕj(x) ∈ R∪ {∞}. Notice that if mj > b, there is a unique value bj ∈ R so that ϕj(bj) = b.
If mj ≤ b, we take bj :=∞. So we define
cj :=
{
ϕ′j(bj) if bj <∞
1 otherwise
In the former case, cj is the marginal antigenicity of Sj at the value bj. We now use the linear
change of coordinates
H : R2n → R2n
(Sj , Tj) 7→ (Sj , T j) := Hj(Sj , Tj) := (cjSj , pjTj).
This gives the equations
dSj
dt
= F̂j(S, T ) = rj−1fj−1Sj−1 − ajSj − fjSj − SjT j(3)
dT j
dt
= Ĝj(S, T ) = ϕj(Sj)T j − bT j
rj =
cj+1
cj
rj
ϕj(Sj) = ϕj
(
Sj
cj
)
Note that for each j, ϕj still enjoys the properties that it is differentiable, ϕ
′
j(x) > 0 for x > 0 and
ϕj(0) = 0. We now take bj to be the unique solution to ϕj(bj) = b, i.e., bj := cjbj, where such
exists. Note that ϕj now enjoys the additional property that ϕ
′
j(bj) = 1. In the case studied in [5],
ϕj(Sj) = cjSj and thus ϕj(Sj) = Sj , giving
dSj
dt
= F̂j(S, T ) = rj−1fj−1Sj−1 − ajSj − fjSj − SjT j(4)
dT j
dt
= Ĝj(S, T ) = SjT j − bT j
We will henceforth drop the bars and assume our equations are given in the form (3). We take a
parameter set θ to be a set of values for b, rj , fj , aj , mj and bj, j = 0, ..., n− 1. When we need to
make an explicit comparison with the ϕj of (2), we will refer to the later as “biological ϕ”, ϕ
bio
j .
We will adopt the following notational conventions. Sets such [j, k] and [j, k) are to be taken
cyclically. That is to say, if j < k, then [j, k] = {j, . . . , k}, while if j > k, [j, k] = {j, . . . , n −
1, 0, . . . , k}. We take [j, j) to be the empty set so that any product taken over [j, j) is equal to one.
We abuse notation by taking [0, n) = {0, . . . , n− 1}
We now review and in some cases generalize the definitions of [5].
Definition 1. Given a fixed point (S∗, T ∗) of (3), the regulated and unregulated stages of (S∗, T ∗)
are
Reg(S∗, T ∗) = {j | T ∗j 6= 0}
Unreg(S∗, T ∗) = {j | T ∗j = 0}
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Definition 2. (S∗, T ∗) is biologically meaningful if S∗j ≥ 0, T
∗
j ≥ 0 for j = 0, . . . , n − 1. It is
infected if for some (hence, all, see 1) below) j, S∗j > 0.
Definition 3. Given a parameter set θ, the self-establishing stages are
SE(θ) = {j | aj + fj < 0}.
Definition 4. The immuno-incompetent stages of θ are
Incomp(θ) = {j | mj ≤ b} = {j | bj =∞}.
Definition 5. If j ∈ SE(θ) ∩ Incomp(θ), we say that the stage j and the parameter set θ are
fatal. We will assume that the host is capable of mounting a response to at least one stage, i.e.,
Incomp(θ) 6= [0, n).
Definition 6. If SE(θ) = ∅, the follow-on constants of θ are
Mj =
rjfj
aj+1 + fj+1
Mjk =
∏
ℓ∈[j,k)
Mℓ
In the case where SE(θ) 6= ∅,Mj is only meaningful for our purposes for j+1 /∈ SE(θ). Accordingly,
Mjk is only meaningful if (j, k] ∩ SE(θ) = ∅. Note that for every k ∈ [j, ℓ) it holds Mjℓ = MjkMkℓ.
Definition 7. We say that j starves k and write j ≻ k if bjMjk < bk. Here we assume that Mjk
is meaningful and that bj is finite, though bk need not be. In particular, if Mjk is meaningful,
j /∈ Incomp(θ), and k ∈ Incomp(θ), then j ≻ k.
Definition 8. The starvable stages of θ are
Str(θ) = {k | there is j so that j ≻ k}.
The unstarvable stages Unstr(θ) are the complement of these.
Definition 9. A biologically meaningful fixed point (S∗, T ∗) is saturated1 if Reg(S∗, T ∗) =
Unstr(θ). It is moderated if for j ∈ Unreg, S∗j < bj .
Definition 10. If SE(θ) = ∅, we define
R0 =
n−1∏
j=0
Mj .
R0 may be interpreted as the number of copies of the pathogen produced by a single copy entering
a naive host ([5]). It is not hard to see that R0 is invariant under the transformation H as befits a
property of the organism being described.
Definition 11. When we say that θ is generic we will require the following:
• R0 6= 1.
• There is no j so that aj + fj = 0.
• There is no pair (j, k) so that bj <∞, bk <∞ and bjMjk = bk.
• At the saturated biologically meaningful fixed point, there are j and k so that T ∗j 6= T
∗
k .
1 There is an unfortunate collision here between the use of the term saturated to denote the host mounting a
T-response to all stages capable of supporting one ([5]) and the meaning of the term used in the Introduction above,
namely, a maximum prolfieration rate, with no increase through further stimulation.
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It is not hard to see that each of these conditions has measure zero, thus justifying the use of
the term generic. The detailed motivation for these exclusions can be found in [5].
Definition 12. Suppose Reg(S∗, T ∗) 6= ∅. Given a stage k, we define hk to be the unique stage
such that hk ∈ Reg(S∗, T ∗) and (hk, k) ⊂ Unreg(S∗, T ∗).
3. Results
We will start by assuming that SE(θ) = ∅. This will be a standing assumption until it is lifted
in Section 3.1.
The linear stability analysis performed in [5] is possible because we were able to calculate the
characteristic polynomial of the Jacobian matrix of the right hand side of (4), which corresponds to
setting ϕj(Sj) = Sj for each j in (3) (recall that we are omitting the bars). Here we contemplate
more general ϕj : R → R, j = 0, ..., n − 1 (which is a consequence of contemplating more general
ϕbioj : R → R) with the properties mentioned above. Consequently, in order to make use of the
results obtained in [5], we need to establish what changes are induced on the Jacobian matrix
through the use of more general functions ϕj . The partial derivatives of the right hand side of ( 3)
are given by
∂F̂k
∂Sj
=

rk−1fk−1 if j = k − 1
−ak − fk − Tk if j = k
0 otherwise
∂F̂k
∂Tj
=
{
−Sk if j = k
0 otherwise
∂Ĝk
∂Sj
=
{
ϕ′k(Sk)Tk if j = k
0 otherwise
∂Ĝk
∂Tj
=
{
ϕk(Sk)− b if j = k
0 otherwise
Since the functions F̂j do not depend on any ϕj , only the partial derivatives
∂Ĝk
∂Sj
and ∂Ĝk
∂Tj
differ
from the results obtained in [5]. As we shall see, most differences vanish when the functions are
evaluated at a fixed point.
Proposition 13.
(1) R0 is the basic reproductive number of the pathogen.
(2) If R0 < 1, the pathogen fails to establish infection and (S
∗, T ∗) = 0 is a local attractor. If
R0 > 1, the pathogen is able to establish infection. In particular, this makes (S
∗, T ∗) = 0
an unstable fixed point.
(3) If R0 < 1, (S
∗, T ∗) = 0 is a global attractor.
Proof. There are two ways to establish the first and second claims. One is by using the interpretation
of R0 in terms of the lifespan and productivity of each stage. The other is by computing the
eigenvalues the Jacobian. We briefly sketch the first approach. In the absence of immune response,
stage 0 has an expected lifespan of 1
a0+f0
. During that time, it produces r0f0
a0+f0
copies of stage 1.
These, in turn, produce r0f0
a0+f0
r1f1
a1+f1
copies of stage 2. Continuing in this way produces R0 copies
of stage 0. If this is greater than 1, the pathogen can establish infection, if less than 1, not.
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To see these two claims using the eigenvalues of the Jacobian, notice that since ϕj(0) = 0,
j = 0, ..., n− 1, the Jacobian matrix evaluated at (S∗, T ∗) = (~0,~0) is identical to the one obtained
in [5, Proposition 1]. Thus the claim follows from Propositions 1 and 2 of [5].
The third claim comes from showing that the reproductive number in the presence of immune
response is no more than the reproductive number in the naive host as in [5, Proposition 1].  
The following correspond to the numbered observations in Section 3 of [5] and follow from the
fixed point equations
S˙j = F̂j(S
∗, T ∗) = rj−1fj−1S
∗
j−1 − S
∗
j (aj + fj + T
∗
j ) = 0
T˙j = Ĝj(S
∗, T ∗) = (ϕj(S
∗
j )− b)T
∗
j = 0
1) Given (S∗, T ∗), if there is j such that S∗j = 0 then (S
∗, T ∗) = 0.
2) If j ∈ Reg(S∗, T ∗), then S∗j = bj .
3) If j ∈ Unreg(S∗, T ∗), then T ∗j = 0.
4) If j + 1 ∈ Unreg(S∗, T ∗), then S∗j+1 = S
∗
jMj .
5) If [j + 1, k] ⊂ Unreg(S∗, T ∗) then S∗k = S
∗
jMjk. This follows by induction on the previous
observation.
6) Assume Reg(S∗, T ∗) 6= ∅. If k ∈ Unreg(S∗, T ∗), then S∗k = bhkMhkk. This follows from 2) and
5).
7) If θ is generic and (S∗, T ∗) 6= 0 then Reg(S∗, T ∗) 6= ∅. Were Reg(S∗, T ∗) = ∅, then by 5)
S∗0 = S
∗
0R0. Consequently R0 = 1, contradicting our first genericity requirement.
8) If j ∈ Reg(S∗, T ∗) then T ∗j =
rj−1fj−1
bj
S∗j−1 − (aj + fj).
9) If j ∈ Reg(S∗, T ∗) then T ∗j = rj−1fj−1
bhj
bj
Mhjj−1 − (aj + fj). This follows from the fact
that S∗j−1 = S
∗
hj
Mhjj−1 (which follows from 6) if j − 1 ∈Unreg(S
∗, T ∗) , and holds trivially, if
j − 1 ∈Reg(S∗, T ∗)) and S∗hj = bhj .
10) If j ∈ Reg(S∗, T ∗), then T ∗j > 0 if and only if bhjMhjj > bj. This follows from the previous
observation; (recall that we have assumed SE(θ) = ∅).
Proposition 14. Suppose θ is generic and (S∗, T ∗) is a biologically meaningful fixed point. Suppose
further that j ≻ k . If j ∈ Reg(S∗, T ∗), then k ∈ Unreg(S∗, T ∗).
Proof. Suppose j ≻ k and j ∈Reg(S∗, T ∗). Let {j = j0, j1, . . . , jm} = [j, k)∩Reg(S∗, T ∗) (cyclically
ordered as listed) and let jm+1 = k. Ifm = 0, then, hk = j and, due to j ≻ k, it holds bhkMhkk < bk.
Thus, the claim follows by observation 10), above. Otherwise we have j 6= jm = hk and it suffices
to show that S∗jmMjmk < bk. For ℓ = 0, . . . ,m, we have jℓ ∈Reg(S
∗, T ∗) so we must have S∗jℓ = bjℓ .
For ℓ = 0, . . . ,m− 1 we must also have S∗jℓ+1 < S
∗
jℓ
Mjℓjℓ+1 , because hjℓ+1 = jℓ. We then have
bj1 = S
∗
j1
< S∗j0Mj0j1
bj2 = S
∗
j2
< S∗j1Mj1j2 < S
∗
j0
Mj0j2
...
bjm = S
∗
jm
< S∗j0Mj0jm = bj0Mj0jm
so that
S∗hkMhkk = S
∗
jm
Mjmk < bj0Mj0k < bk.
Thus k ∈Unreg(S∗, T ∗) as required.  
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Proposition 15. Let θ be a generic parameter set such that R0 > 1. Then ≻ is a strict partial
order.
Proof. We must show that ≻ is anti-reflexive, asymmetric and transitive. The first follows imme-
diately from the fact that Mjj = 1.
To see that ≻ is asymmetric, suppose we have j ≻ k and k ≻ j . We then have bjMjk < bk and
bkMkj < bj . This gives bj > bjMjkMkj . But MjkMkj = R0, contradicting R0 > 1.
To see the third we suppose that j ≻ k and k ≻ ℓ. We consider two cases, k ∈ [j, ℓ] and
ℓ ∈ [j, k]. In the first case, we have MjkMkℓ = Mjℓ. We then have bjMjk < bk , bkMkℓ < bℓ giving
bjMjℓ = bjMjkMkℓ < bkMkℓ < bℓ as required. In the second case, we have MjkMkℓ = R0Mjℓ, so
that bjR0Mjℓ = bjMjkMkℓ < bkMkℓ < bℓ. Since R0 > 1, this implies j ≻ ℓ as required.  
Remark 16. Since ≻ is a partial order, it is cycle-free, that is there is no sequence of stages
j0 ≻ jj ≻ . . . ≻ j0. Consequently, we can define the depth of a stage k, d(k) to be the length of the
longest chain j0 ≻ . . . ≻ jd(k) = k. It follows that Unstr(θ) consists of the stages of depth 0. In
particular, Unstr(θ) 6= ∅. Note that if θ is such that no two stages are comparable, then ≻ is empty
and every stage is ≻-maximal, so Unstr(θ) = [0, n). Str(θ) consists of the stages of positive depth.
If Incomp(θ) 6= ∅, Incomp(θ) consists of the stages of maximal depth.
Proposition 17. Suppose that θ is generic. Furthermore, let (S∗, T ∗) be a biologically meaningful
infected fixed point. Then the pathogen populations are moderated at (S∗, T ∗) if and only if the
immune response is saturated at (S∗, T ∗).
Proof. We first show that if (S∗, T ∗) is moderated, then (S∗, T ∗) is saturated.
We claim Unstr(θ)⊆Reg(S∗, T ∗). Suppose to the contrary j ∈Unstr(θ)∩Unreg(S∗, T ∗). By
assumption (S∗, T ∗) is moderated, so S∗j < bj . Since j ∈ Unreg(S
∗, T ∗), by 7), 6) and 2) above,
S∗j = S
∗
hj
Mhjj = bhjMhjj . This gives bhjMhjj < bj , i.e., hj ≻ j, contradicting the assumption that
j ∈ Unstr(θ). This proves the claim.
We claim that Str(θ) ⊆Unreg(S∗, T ∗). If Str(θ) = ∅, this holds trivially. Suppose k ∈ Str(θ).
Then there is a maximal j so that j ≻ k. Being maximal j ∈ Unstr(θ) and thus j ∈Reg(S∗, T ∗). It
follows by Proposition 14 that k ∈Unreg(S∗, T ∗) as required.
We now show that if (S∗, T ∗) is saturated, then (S∗, T ∗) is moderated.
If Unreg(S∗, T ∗) = ∅, the claim holds vacuously. Suppose that k ∈Unreg(S∗, T ∗). We must
show that S∗k < bk. Again, we choose j to be maximal so that j ≻ k. Since (S
∗, T ∗) is saturated,
j ∈Reg(S∗, T ∗) , thus, by 2) S∗j = bj. If [j + 1, k) ⊆ Unreg(S
∗, T ∗), we are done, for then
S∗k = S
∗
jMjk = bjMjk < bk. On the other hand if [j + 1, k) ∩ Reg(S
∗, T ∗) 6= ∅, choose m ∈
[j + 1, k) ∩ Reg(S∗, T ∗) so that m = hk. Since m ∈ Reg(S∗, T ∗), by the assumed saturation
m ∈ Unstr(θ). Therefore j ⊁ m, in other words, bjMjm ≥ bm. If bmMmk ≥ bk, these two
inequalities would yield bjMjk = bjMjmMmk ≥ bk contradicting j ≻ k. Consequently bmMmk < bk
must hold. Now we have S∗k = S
∗
mMmk = bmMmk < bk as required.  
Theorem 18. Suppose θ is generic and (S∗, T ∗) is a biologically meaningful infected fixed point
which is not saturated. Then there is j ∈ Unreg(S∗, T ∗) so that for any open neighborhood U of
(S∗, T ∗) there is a biologically meaningful point x ∈ U so that dTj
dt
∣∣
x
> 0 . In particular (S∗, T ∗) is
unstable.
Proof. Since (S∗, T ∗) is not saturated, it is not moderated. Thus, there is j ∈ Unreg(S∗, T ∗) with
S∗j ≥ bj . Since θ is generic, S
∗
j > bj , for otherwise we would have bhjMhjj = bj . In particular,
bj <∞. It follows that j /∈ Incomp(θ). Since S∗j > bj , ϕj(S
∗
j ) > b, so
∂Ĝj
∂Tj
|(S∗,T∗) = ϕj(Sj)− b > 0.
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Let eTj be the unit vector in the Tj direction. Then, for any δ > 0, T˙j |(S∗,T∗)+δeTj > 0. Thus, in
any open neighborhood U of (S∗, T ∗), there are biologically meaningful points whose orbits move
away from (S∗, T ∗). In particular, (S∗, T ∗) is unstable as required.  
Theorem 19. Suppose that θ is generic and that (S∗, T ∗) is a biologically meaningful infected
fixed point. In particular, not all T ∗j are equal. If (S
∗, T ∗) is moderated then (S∗, T ∗) is a local
asymptotically stable equilibrium. In particular, the eigenvalues of the Jacobian matrix J(S∗, T ∗)
have strictly negative real part.
Corollary 20. For a generic parameter set, the system ( 3) (and hence (2)) has a unique biologically
meaningful stable fixed point.
Proof. Since the sets of starvable and unstarvable stages depend only on θ, there is exactly one
saturated fixed point, hence exactly one moderated fixed point. The Corollary now follows from
the Theorem.  
Theorem 19. The proof of the corresponding Theorem in [5] proceeds by showing that the Jacobian
matrix of the system (4 ) has eigenvalues all of whose real parts are negative. It will therefore suffice
to show that we can carry out the same computation on the Jacobian matrix of (3) evaluated at a
moderated fixed point (S∗, T ∗). Since H and Ĥ are identical, we need only consider the partials of
G and Ĝ. We have
∂Gk
∂Sj
=
{
Tk if j = k
0 otherwise
∂Ĝk
∂Sj
=
{
ϕ′k(Sk)Tk if j = k
0 otherwise
Now for k ∈ Unreg(S∗, T ∗), both of these partial derivatives vanish, while if k ∈ Reg(S∗, T ∗), We
then have S∗k = bk so that ϕ
′
k(S
∗
k) = 1, and once again, the two are identical.
Moreover, we have
∂Gk
∂Tj
=
{
Sk − b if j = k
0 otherwise
∂Ĝk
∂Tj
=
{
ϕk(Sk)− b if j = k
0 otherwise
Now if k ∈ Reg(S∗, T ∗), we have S∗k = b so that Sk−b = 0 in the former case, while in the latter case
we have S∗k = bk so that ϕk(S
∗
k) − b = 0. Finally, in the case where k ∈ Unreg(S
∗, T ∗), the proof
of [5, Theorem 2] appeals to the fact that (S∗, T ∗) is moderated, thus ensuring that S∗k − b < 0.
Here, the fact that (S∗, T ∗) is moderated implies that S∗k < bk so that ϕk(S
∗
k) − b < 0 and we can
proceed as before.  
3.1. Self-establishing stages. We now turn to the case where SE(θ) 6= ∅ . In this case we need
the assumption that θ is not fatal, that is, SE(θ) ∩ Incomp(θ) = ∅ and Incomp(θ) 6= [0, n).
We start by observing that if SE(θ) 6= ∅, then the pathogen is viable. Accordingly, in place of
Proposition 13, we have the following.
Proposition 21. If SE(θ) 6= ∅, then (S∗, T ∗) = (0, 0) is an unstable equilibrium. In particular, the
pathogen is able to infect the host.
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Proof. Suppose that j ∈ SE(θ). Then ∂F̂j
∂Sj
|(0,0) = −aj − fj > 0. This gives orbits with positive and
increasing Sj inside any open set around (0, 0).  
The numbered observations 1) through 9) listed above hold without change. Observation 10)
now requires the additional hypothesis that j /∈ SE(θ), giving
10′) If j ∈ Reg(S∗, T ∗) and j /∈ SE(θ), then T ∗j > 0 if and only if bhjMhjj > bj.
As before, this follows from observation 9).
Proposition 22. Suppose that SE(θ) 6= ∅ and (S∗, T ∗) is a biologically meaningful infected fixed
point. Then SE(θ) ⊆ Reg(S∗, T ∗).
Proof. This follows from noting that j ∈ SE(θ), S∗j > 0 and T
∗
j = 0 implies S˙j > 0.  
Proposition 23. 2 Suppose SE(θ) 6= ∅. Then ≻ is a strict partial order.
Proof. We must show that ≻ is anti-reflexive, asymmetric and transitive. The first follows imme-
diately from the fact that Mjj = 1.
To see that ≻ is asymmetric, suppose we have j ≻ k and k ≻ j . This implies (j, k]∩SE(θ) = ∅
and (k, j]∩SE(θ) = ∅, contradicting SE(θ) 6= ∅.
To see the third we suppose that j ≻ k and k ≻ ℓ. We consider two cases, k ∈ [j, ℓ] and
ℓ ∈ [j, k]. In the first case, we have MjkMkℓ = Mjℓ. We then have bjMjk < bk , bkMkℓ < bℓ giving
bjMjℓ = bjMjkMkℓ < bkMkℓ < bℓ as required. The second case would imply (j, k] ∪ (k, ℓ] = [0, n)
as well as (j, k]∩SE(θ) = ∅ and (k, ℓ]∩SE(θ) = ∅, contradicting SE(θ) 6= ∅.  
We define Str(θ), Unstr(θ), saturated and moderated as before. Proposition 14 holds in the case
SE(θ) 6= ∅. However, there is a small change in the proof. In the case where SE(θ) = ∅, we appeal
to observation 10). In the case where SE(θ) 6= ∅, we need to note that j ≻ k implies that k /∈ SE(θ)
and we are thus able to appeal to observation 10′. The proof then proceeds as before.
The equivalence of moderation and saturation (Proposition 17) and their necessity for stability
(Theorem 18) can be proved as before, the result of Proposition 22 playing an important role.
In order to prove sufficiency in the presence of self-establishing stages (Theorem 19 and its
consequences), we rely on Lemma 1 of Section 8 in [5] and the argument provided there after the
Proof of the Lemma.
4. Discussion
In this paper, we have generalized the T-cell activation and proliferation model of [5] in order
to make that model applicable to more realistic antigen dose - T-cell proliferation response curves.
While in most regimes, we would expect T-cell proliferation to rise in response to increased anti-
gen, this rate is not driven by the encounter of T-cells with infected target cells, but rather by the
presentation of antigen to T-cells by dendritic cells ([12]). Thus, a model of the mechanisms un-
derlying T-cell proliferation must include additional cell populations and quite complicated cellular
processes carried out by those cells ([18]).
Further, there is a widespread phenomenon that cannot be explained as the fixed point of a
system like (3), namely the existence of long-lived T-cell responses to multiple epitopes, either of
a single pathogen or in our case to a single pathogen stage. Multiple T-cell responses are often
2We take the opportunity to amend Proposition 7 of Section 8 in [5]. The condition R0 > 1 in the statement of
that proposition is not required, given that we take SE(θ) 6= ∅ as a standing assumption for the entire Section 8.
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modeled as competing for antigen in a predator-prey dynamic. The antigenicity of the T-cell’s
epitope functions as the T-cell’s fitness and this leads to a winner-take-all dynamic where the
response to the most antigenic epitope survives and the others become extinct ([13], [17]). It seems
likely that memory T-cells play an important role in the survival of multiple responses. However,
the interactions between effector and memory populations are still not well understood ([4], [1]).
These populations exhibit differing longevity. Stated in terms of our model, they do not share
a common value for b. In addition, high levels of antigen can lead to CTL exhaustion ([11]), a
phenomenon that argues against a monotone increasing ϕ.
The upshot of this is that if we wish to refine the cyclic pathogen model to present an increas-
ingly detailed picture of the cell populations and their mechanisms, we will need to include multiple
immune cell populations at each stage. The dynamics of such a system could be quite compli-
cated. However, there is a variable that summarizes the collective immune pressure against a given
stage, namely their net kill rate of the effector populations. Thus, if Tj1, . . . , Tjk are the effector
populations against stage Sj , we can write τj = τj(Tj1, . . . , Tjk) so that we now have
dSj
dt
= rj−1fj−1Sj−1 − (aj + fj + τj)Sj .
We cannot expect that the dynamics of such an expanded system can be mapped to the dynamics
of (3) because we cannot necessarily expect Tj1, . . . , Tjk (and any non-effector populations) to vary
in a way which makes
dτj
dt
a function of Sj and τj . However, once the dynamics of these populations
are understood, in the neighborhood of a fixed point, understanding the marginal response of τj to
Sj may allow us to use (3) to summarize these dynamics in a way which will allow us to establish
the existence of a stable fixed point.
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